Drug Search Results
More Filters [+]

Denatonium benzoate

Alternative Names: denatonium benzoate, aversion
Latest Update: 2024-08-25
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Chile | Pakistan

Approved Indications: None

Known Adverse Events: None

Company: Universitaire Ziekenhuizen KU Leuven
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Denatonium benzoate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Obesity

Phase 3: Colorectal Cancer

Phase 1: Type 2 Diabetes|Obesity

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2300071590

N/A

Not yet recruiting

Alcoholism

2025-06-30

Pro00111134

N/A

Completed

Spinal Dysraphism|Urinary Bladder, Neurogenic

2024-04-18

DINE

N/A

Completed

Weight Loss|Acute Respiratory Distress Syndrome|Obesity|Communicable Diseases

2022-10-26

MM-BP

N/A

Completed

Depressive Disorder

2022-04-10

Recent News Events